Atypigene Biomedical Research Institute (ABRI) is an independent, non-profit institution dedicated to biomedical research that promotes the understanding, treatment and prevention of cancer. Areas of research include studies of atypical genes that are not typically expressed in the adult human. These highly selective gene expressions can be targeted to inhibit the mechanisms of cellular behaviors required for these diseases.